Related Experiment Videos
Cells deficient in DNA polymerase beta are hypersensitive to alkylating agent-induced apoptosis and chromosomal
K Ochs1, R W Sobol, S H Wilson
1Division of Applied Toxicology, Institute of Toxicology, University of Mainz, Germany.
Abstract:
DNA polymerase beta (beta-pol), which is involved in base excision repair, was investigated for its role in protection of cells against various genotoxic agents and cytostatic drugs using beta-pol knockout mouse fibroblasts. We show that cells lacking beta-pol are highly sensitive to induction of apoptosis and chromosomal breakage by methylating agents, such as N-methyl-N'-nitro-N-nitrosoguanidine and methyl methanesulfonate and the cross-linking antineoplastic drugs mitomycin C and mafosfamide. The cross-sensitivity between the agents observed suggests that beta-pol is involved in repair not only of DNA methylation lesions but also of other kinds of DNA damage induced by various cytostatic drugs. Cells deficient in beta-pol were not hypersensitive to cisplatin, melphalan, benzo(a)pyrene diol epoxide, chloroethylnitrosourea, or UV light. Because both established and primary beta-pol knockout fibroblasts displayed the hypersensitive phenotype, which, moreover, was complemented by transfection with a beta-pol expression vector, the alkylating agent hypersensitivity can clearly be attributed to the beta-pol deficiency. The results demonstrate that beta-pol-driven base excision repair is highly important for protection of cells against cell killing due to apoptosis and induced chromosomal breakage and suggest that incompletely repaired DNA damage causes chromosomal changes and may act as a trigger of DNA damage-induced apoptosis.
Insights
DNA polymerase beta (beta-pol) deficiency increases sensitivity to DNA damage. Cells lacking beta-pol exhibit heightened apoptosis and chromosomal breakage from specific genotoxic agents, indicating its crucial repair role.
Area of Science:
- Molecular Biology
- Genetics
- Cell Biology
Background:
- DNA polymerase beta (beta-pol) is a key enzyme in base excision repair.
- Understanding beta-pol's protective mechanisms against genotoxic agents is crucial for cancer therapy and toxicology.
Purpose of the Study:
- To investigate the role of beta-pol in cellular protection against various genotoxic agents and cytostatic drugs.
- To determine the specific types of DNA damage that beta-pol is involved in repairing.
Main Methods:
- Utilized beta-pol knockout mouse fibroblasts to assess sensitivity to genotoxic agents.
- Compared cellular responses (apoptosis, chromosomal breakage) in beta-pol deficient cells versus wild-type cells.
- Complemented knockout cells with beta-pol expression vector to confirm enzyme's role.
Main Results:
- Cells lacking beta-pol showed high sensitivity to methylating agents (MNNG, MMS) and cross-linking drugs (mitomycin C, mafosfamide).
- Beta-pol deficiency did not confer hypersensitivity to cisplatin, melphalan, BPDE, CCNU, or UV light.
- Hypersensitivity phenotype in knockout fibroblasts was confirmed and complemented by beta-pol reintroduction.
Conclusions:
- Beta-pol-driven base excision repair is vital for protecting cells against DNA methylation and cross-linking damage.
- Incompletely repaired DNA damage contributes to chromosomal alterations and triggers apoptosis.
- Beta-pol plays a significant role in preventing cell death and maintaining genomic stability against specific cytotoxic agents.